• Publications
  • Influence
The impact of automated eGFR reporting and education on nephrology service referrals
TLDR
The introduction of automated eGFR calculation has led to an overall increase in referrals with a small but significant decrease in referral quality, and was seen predominantly in older and diabetic patients with stage 3 CKD and appeared to result in net benefit.
A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial.
TLDR
HIP showed no clear safety or efficacy benefit in PD patients compared with conventional oral iron supplements, and the reduction in serum ferritin levels and high costs associated with HIP therapy suggest that this agent is unlikely to have a significant role in iron supplementation inPD patients.
Urine and serum midkine levels in an Australian chronic kidney disease clinic population: an observational study
TLDR
MK levels sequentially rise with CKD stage beyond stage 2, and the data support existing animal evidence for an MK/renin angiotensin-system/proteinuria relationship.
Data quality of the Australia and New Zealand Dialysis and Transplant Registry: A pilot audit
TLDR
Most clinical registries in Australia, including the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), do not audit submitted data and this study aimed to audit data submitted to ANZDATA from a single region.
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT
TLDR
This investigator-initiated multicentre study has been designed to provide evidence to help nephrologists and their peritoneal dialysis patients determine whether HIP administration more effectively augments iron stores in ESP-treated PD patients than conventional oral iron supplementation.
...
1
2
...